Investor Alert

July 23, 2021, 6:39 a.m. EDT

Antibacterial Drugs Market Size, Top Key Players, Latest Trends, Regional Insights and Global Industry Dynamics By 2028

The Antibacterial Drugs market is expected to cross US$ 38 Billion by 2024 growing at a CAGR of 1% during the given forecast period.

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Jul 23, 2021 (Heraldkeepers) -- The term Antibiotic refers to antimicrobials which are obtained or derived from the bacteria or molds. Antibacterial drugs have different modes of action which includes increasing the cell membrane permeability, interfering with protein synthesis, nucleic acid metabolism, inhibiting cell wall synthesis. These drugs are used in the treatment as well as prevention of bacterial infection. These antibiotic drugs inhibit the growth of or kill the bacteria.The term antibiotic is used to refer to any substance used against microbes.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/antibacterial-drugs-market

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Allergen plc, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Merck & Co., Inc. Novartis AG, Pfizer, Inc., and Sanofi. are provided in the report. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Antibacterial Drugs market is expected to cross US$ 38 Billion by 2024 growing at a CAGR of 1% during the given forecast period.

The scope of the report includes a detailed study of global and regional markets for various types of Antibacterial Drugs Market with the reasons given for variations in the growth of the industry in certain regions.

The Antibacterial drugs Market has segmented as below:

The Antibacterial Drugs Market is Segmented on the lines of Drug Class and Geography. BY Drug Class this market is segmented on the basis ofAminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones/Fluoroquinolones, Macrolides, Phenicols and Miscellaneous Antibacterials.

BY Geographythis market is segmented on the basis ofNorth America, Asia Pacific, Europe, Latin America and Africa and Middle East.

This report provides:

1) An overview of the global Antibacterial Drugs Market and related technologies.
2) Analyses of global market trends and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Antibacterial Drugs Market.

4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The major driving factors of Antibacterial Drugs Market are as follows:

  • There is a very high prevalence of infectious diseases.

  • The research and development activities have increased.

  • Product differentiation through various methods.

  • Increased government support.

The restraining factors of Antibacterial drugs Market are as follows:

  • Rise in drug resistant species.

  • Launch of the generic drugs.

  • Patent expiry.

Request Sample Report:


Table of Contents

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Market Overview

Chapter 4 Global Antibacterial Drugs Market Revenue, by Class, 2013 – 2023 (USD Million)

Chapter 5 Global Antibacterial Drug Pipeline Analysis

5.1 Introduction

5.2 Actoxumab/bezlotoxumab (MK-3415A)

5.2.1 Actoxumab/Bezlotoxumab (MK-3415A) Market Revenue, 2016 - 2022 (USD Million)

5.3 Surotomycin (MK-4261)

5.3.1 Surotomycin (MK-4261) Market Revenue, 2016 - 2022 (USD Million)

5.4 Arikace

5.4.1 Arikace Market Revenue, 2017 - 2022 (USD Million)

5.5 Cadazolid

5.5.1 Cadazolid Market Revenue, 2016 - 2022 (USD Million)

5.6 Ciprofloxacin/Fluocinolone Acetonide

5.6.1 Ciprofloxacin/Fluocinolone Acetonide Market Revenue, 2016 - 2022 (USD Million)

5.7 Zempia (E-101)

5.7.1 Zempia (E-101) Market Revenue, 2017 - 2022 (USD Million)

5.8 Carbavance (meropenem/RPX7009)

5.8.1 Carbavance Market Revenue, 2017 - 2022 (USD Million)

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.